Share on StockTwits

GlycoMimetics (NASDAQ:GLYC) announced its earnings results on Thursday. The company reported $0.39 EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.08) by $0.47, Stock Ratings Network reports. The company had revenue of $15.03 million for the quarter, compared to the consensus estimate of $9.08 million. The company’s quarterly revenue was up 27221.8% on a year-over-year basis.

GlycoMimetics (NASDAQ:GLYC) traded down 3.19% during mid-day trading on Thursday, hitting $8.19. The stock had a trading volume of 32,207 shares. GlycoMimetics has a 52-week low of $6.02 and a 52-week high of $18.99. The stock’s 50-day moving average is $8.04 and its 200-day moving average is $10.5. The company’s market cap is $153.9 million.

GlycoMimetics, Inc (NASDAQ:GLYC) is a clinical-stage biotechnology company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.